Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids

Journal of Gastroenterology

Volumn 46, Issue 6, 2011, Pages 834-842

  Kubota, Kensuke ^a   Watanabe, Seitaro ^a   Uchiyama, Takashi ^a   Kato, Shingo ^a   Sekino, Yusuke ^a   Suzuki, Kaori ^a   Mawatari, Hironori ^a   Iida, Hiroshi ^a   Endo, Hiroki ^a   Fujita, Koji ^a   Yoneda, Masato ^a   Takahashi, Hirokazu ^a   Kirikoshi, Hiroyuki ^a   Kobayashi, Noritoshi ^a   Saito, Satoru ^a   Sugimori, Kazuya ^b   Hisatomi, Kantaro ^c   Matsuhashi, Nobuyuki ^c   Sato, Hirotaka ^d   Tanida, Emiko ^e   Sakaguchi, Takashi ^f   Fujisawa, Nobutaka ^g   Nakajima, Atsushi ^a   more..

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c NTT Kanto Medical Center   (Japan)

^d Yokohama Sakae Kyosai Hospital   (Japan)

^e Machida City Hospital   (Japan)

^f Hiratsuka City Hospital   (Japan)

^g TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

Author keywords

AIP; Relapse; Spontaneous remission

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN G4;

ABDOMINAL PAIN; AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; CLINICAL FEATURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DUODENUM DISEASE; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE JAUNDICE; PANCREATICODUODENECTOMY; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; REMISSION; SWELLING; TREATMENT DURATION; TREATMENT INDICATION; VATER PAPILLA;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; JAUNDICE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREATITIS; PROSPECTIVE STUDIES; RECURRENCE; REMISSION, SPONTANEOUS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79960283036     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-011-0393-y     Document Type: Article

References (25)

1. Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas: an autonomous pancreatic disease? Am J Dig Dis. 1961;6:688-98.
2. Yoshida K, Toki F, Takeuti T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561-8.
3. Hamano H, Kawa S, Horiuchi A, Unnno H, Furuta N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-8. (Pubitemid 32204991)
4. Erkelens GW, Vleggaar FP, Lesterhuis W, van Buuren HR, van der Werf SD. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet. 1999;354:43-4. (Pubitemid 29304304)
5. Kubota K, Iida H, Fujisawa T, Yoneda M, Inamori M, Kirikoshi H, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc. 2007;66:1142-51. (Pubitemid 350186013)
6. Wakabayashi T, Kawaura Y, Satomura Y, Watanabe H, Motoo Y, Sawabu N. Long-term prognosis of duct-narrowing chronic pancreatitis. Strategy for steroid treatment. Pancreas. 2005;30: 31-9. (Pubitemid 40070624)
7. Takayama M, Hamano H, Ochi Y, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol. 2004;99:932-7. (Pubitemid 39090226)
8. Hirano K, Tada M, Isayama H, Yagioka H, Sasaki T, Kogure H, et al. Long term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut. 2006;56:1719-24.
9. Sah RP, Chari ST, Pannala R, Sugumar A, Clain JE, Levy MJ, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;139: 140-8.
10. Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levt MJ, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134: 706-15. (Pubitemid 351312724)
11. Kubota K, Iida H, Fujisawa T, Ogawa M, Inamori M, Saito S, Kakuta Y, Oshiro H, Nakajima A. Clinical significance of swollen duodenal papilla in autoimmune pancreatitis. Pancreas. 2007;35:e51-60.
12. Otsuki M, Chung JB, Okazaki K, Kim MH, Kamisawa T, Kawa S, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol. 2008;43:403-8. (Pubitemid 351997876)
13. Bodily KD, Takahashi N, Fletcher JG, Finder J, Hough DM, Kawashima A, Chari ST. Autoimmune pancreatitis: pancreatic and extrapancreatic imaging findings. AJR. 2009;192:431-7.
14. Kamisawa T, Shimosegawa T, Okazaki K, Nishino T, Watanabe H, Kanno A, et al. Standard steroid therapy for autoimmune pancreatitis. GUT. 2009;58:1504-7.
15. Ghazale A, Chari S. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut. 2007;56:1650-2. (Pubitemid 350206287)
16. Chari ST. Autoimmune pancreatitis, part II: the relapse. Gastroenterology. 2008;134:625-8. (Pubitemid 351173067)
17. Nakazawa T, Ohara H, Sano H, Ando T, Joh T. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas. 2006;32:229.
18. Ito T, Nishimori I, Inoue N, Kawabe K, Gibo J, Arita Y, et al. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol. 2007;24(Suppl 18):50-8. (Pubitemid 46863938)
19. Unno H, Saegusa H, Fukushima M, Hamano H. Usefulness of endoscopic observation of themain duodenal papilla in the diagnosis of sclerosing pancreatitis. Gastrointest Endosc. 2002;56:880-4. (Pubitemid 36236720)
20. Nishimori I, Tamakoshi A, Kawa S, Tanaka S, Takeuti K, Kamisawa T, et al. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Pancreas. 2006;32: 244-8.
21. Ito T, Kawabe K, Arita Y, Hisano T, Igarashi H, Funakoshi A, et al. Evaluation of pancreatic endocrine function in patients with autoimmune pancreatitis. Pancreas. 2006;34:254-9.
22. Uchida K, Yazumi S, Nishio A, Kusuda T, Koyabu M, Furuta M, et al. Long-term outcome of autoimmune pancreatitis. J Gastroenterol. 2009;44:726-32.
23. Tomiyama T, Uchida K, Matsushita M, Ikeura T, Fukui T, Takaoka M, et al. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis. J Gastroenterol. 2009;44:726-32.
24. Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M, working members of research committee for intractable pancreatic disease and Japan Pancreas Society. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol. 2010;45:471-7.
25. Park DH, Kim MH, Oh HB, Kwon OJ, Choi YJ, Lee SS, et al. Substitution of aspartic acid at position 57 of the DQb1 affects relapse of autoimmune pancreatitis. Gastroenterology. 2008;134: 440-6. (Pubitemid 351173047)